A SMART Design for Attendance-based Prize CM
| Status: | Completed |
|---|---|
| Conditions: | Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 11/8/2014 |
| Start Date: | January 2009 |
| End Date: | November 2014 |
| Contact: | Ellen M Ciesielski, B.A. |
| Email: | eciesielski@uchc.edu |
| Phone: | 860-679-4556 |
The purpose of this study is to compare different forms of treatment for substance abuse.
This study will involve a type of treatment called contingency management, in which patients
receive incentives (prizes) for attending outpatient treatment. This study will compare
contingency management to standard treatment that does not involve incentives. This study
will also compare contingency management treatment that lasts 6 weeks to contingency
management that lasts 12 weeks. Finally, this study will compare contingency management
treatment delivered at the beginning of outpatient treatment to contingency management
treatment delivered later during outpatient treatment. The investigators hypothesize that
(1) a 12-week attendance-based contingency management intervention will improve retention
and enhance drug abstinence versus standard treatment, (2) initial short-term exposure to
attendance-based contingency management (in weeks 1-6 only) will improve substance abuse
treatment outcomes compared to standard treatment alone, and (3) contingency management in
weeks 7-12 will be particularly useful for those with sporadic attendance or continued drug
use during initial stages of treatment.
This study will involve a type of treatment called contingency management, in which patients
receive incentives (prizes) for attending outpatient treatment. This study will compare
contingency management to standard treatment that does not involve incentives. This study
will also compare contingency management treatment that lasts 6 weeks to contingency
management that lasts 12 weeks. Finally, this study will compare contingency management
treatment delivered at the beginning of outpatient treatment to contingency management
treatment delivered later during outpatient treatment. The investigators hypothesize that
(1) a 12-week attendance-based contingency management intervention will improve retention
and enhance drug abstinence versus standard treatment, (2) initial short-term exposure to
attendance-based contingency management (in weeks 1-6 only) will improve substance abuse
treatment outcomes compared to standard treatment alone, and (3) contingency management in
weeks 7-12 will be particularly useful for those with sporadic attendance or continued drug
use during initial stages of treatment.
Inclusion Criteria:
- age > 18 years
- current DSM-IV diagnosis of cocaine abuse or dependence or recent cocaine use
(self-reported use in past 30 days or positive urine toxicology screen)
- willing to sign informed consent and able to pass an informed consent quiz
Exclusion Criteria:
- serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar
disorder, severe or psychotic major depression, or suicide risk) on the basis of
history or medical examination
- in recovery from pathological gambling (meet DSM-IV criteria for lifetime
pathological gambling and are actively trying to refrain from gambling)
- do not speak English (all treatment is provided in English at these clinics)
We found this trial at
1
site
263 Farmington Ave
Farmington, Connecticut 06030
Farmington, Connecticut 06030
(860) 679-2000
University of Connecticut Health Center UConn Health is a vibrant, integrated academic medical center that...
Click here to add this to my saved trials
